Qiu-Ming Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Qiu-Ming Yao has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Jin-An Zhang
Department of Endocrinology and Rheumatology, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital
6 shared publications - Ronghua Song
Department of Endocrinology and Rheumatology, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, China
5 shared publications Ling Li
Department of Endocrinology, Jinshan Hospital of Fudan University, No. 1508 Longyang Road, Jinshan District, Shanghai 201508, China
3 shared publications- Wen Wang
Department of Endocrinology, Jinshan Hospital of Fudan University, No. 1508 Longhang Road, Jinshan District, Shanghai 201508, China
3 shared publications Xiao-Fei An
Department of Endocrinology, Jinshan Hospital of Fudan University, No. 1508 Longyang Road, Jinshan District, Shanghai 201508, China
3 shared publicationsKaida Mu
Department of Endocrinology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, No. 1500 Zhouyuan Road, Pudong New District, Shanghai 201318, China
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- p. 1-11
Social Risk Profile, Planetary Health Diet, and Mortality Risk in Individuals with Metabolic Dysfunction–Associated Steatotic Liver Disease: A Population-Based Study
Background/Aims: The individual and combined associations of social vulnerability and diet quality with long-term health outcomes in metabolic dysfunction–associated steatotic liver disease (MASLD) remain unclear. The authors aimed to examine the independent and cumulative associations of diet quality and social vulnerability with all-cause and cardiovascular disease (CVD) mortality among US adults with MASLD. Materials and Methods: The authors included 13 518 adults with MASLD from the 1999-2018 National Health and Nutrition Examination Survey, with mortality follow-up through 2019. Diet quality was assessed using the planetary health diet index (PHDI) based on 24-hour dietary recalls. Social vulnerability was evaluated using a composite social risk profile (SRP) score. Cox proportional hazards models were used to derive hazard ratios (HRs) with 95% CIs. Results: Over a median follow-up of 104 months, 1875 deaths, including 643 from CVD, were recorded. Lower PHDI and SRP scores were each associated with significantly higher risks of all-cause and CVD mortality (all P < .05). In the joint analysis, participants with both the lowest PHDI tertile and an SRP score of 0-2 had the highest hazards for all-cause (HR = 3.86, 95% CI: 2.86-5.20) and CVD mortality (HR = 4.94, 95% CI: 2.97-8.20) compared with those with the highest PHDI tertile and an SRP score of 6-8. Subgroup analysis revealed that the associations of SRP score and PHDI with all-cause mortality were stronger among adults younger than 65 years (P for interaction < .001). Conclusion: Poor diet quality and social disadvantage were independently and jointly associated with increased mortality risk among US adults with MASLD, particularly those younger than 65 years. Cite this article as: Li X, Fan H, Yao Q, Gu X. Social risk profile, planetary health diet, and mortality risk in individuals with metabolic dysfunction–associated steatotic liver disease: A population-based study. Turk J Gastroenterol. Published online August 25, 2026. doi: 10.5152/tjg.2026.26301.
- 25 August 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- p. 1-11
Open AccessSocial Risk Profile, Planetary Health Diet, and Mortality Risk in Individuals with Metabolic Dysfunction–Associated Steatotic Liver Disease: A Population-Based Study
Background/Aims: The individual and combined associations of social vulnerability and diet quality with long-term health outcomes in metabolic dysfunction–associated steatotic liver disease (MASLD) remain unclear. The authors aimed to examine the independent and cumulative associations of diet quality and social vulnerability with all-cause and cardiovascular disease (CVD) mortality among US adults with MASLD. Materials and Methods: The authors included 13 518 adults with MASLD from the 1999-2018 National Health and Nutrition Examination Survey, with mortality follow-up through 2019. Diet quality was assessed using the planetary health diet index (PHDI) based on 24-hour dietary recalls. Social vulnerability was evaluated using a composite social risk profile (SRP) score. Cox proportional hazards models were used to derive hazard ratios (HRs) with 95% CIs. Results: Over a median follow-up of 104 months, 1875 deaths, including 643 from CVD, were recorded. Lower PHDI and SRP scores were each associated with significantly higher risks of all-cause and CVD mortality (all P < .05). In the joint analysis, participants with both the lowest PHDI tertile and an SRP score of 0-2 had the highest hazards for all-cause (HR = 3.86, 95% CI: 2.86-5.20) and CVD mortality (HR = 4.94, 95% CI: 2.97-8.20) compared with those with the highest PHDI tertile and an SRP score of 6-8. Subgroup analysis revealed that the associations of SRP score and PHDI with all-cause mortality were stronger among adults younger than 65 years (P for interaction < .001). Conclusion: Poor diet quality and social disadvantage were independently and jointly associated with increased mortality risk among US adults with MASLD, particularly those younger than 65 years. Cite this article as: Li X, Fan H, Yao Q, Gu X. Social risk profile, planetary health diet, and mortality risk in individuals with metabolic dysfunction–associated steatotic liver disease: A population-based study. Turk J Gastroenterol. Published online August 25, 2026. doi: 10.5152/tjg.2026.26301.
- Open Access
- 24 June 2019
- Published by Wiley in International Journal of Endocrinology
- Vol. 2019, 1-7
Aberrant Histone Methylation in Patients with Graves’ Disease
Background. Graves’ disease (GD) is an organ-specific autoimmune disease. Accumulated data have indicated that aberrant epigenetic modifications are associated with many autoimmune disorders. However, it remains unknown whether histone methylation plays a role in the pathogenesis of GD. In the present study, we aimed to assess histone modification patterns in peripheral blood mononuclear cells (PBMCs) from GD patients. The rate (degree) of H3K4 and H3K9 methylation and the expressions of histone-modifying genes were investigated.Methods. A total of 68 GD patients and 32 healthy controls were enrolled in this study. Global histone H3K4/H3K9 methylation of PBMCs was evaluated by the EpiQuik™ global histone H3K4/H3K9 methylation assay kit. The expressions of histone methyltransferases (HMTs) and histone demethylases (HDMs) at the mRNA level were determined by real-time quantitative polymerase chain reaction.Results. Global histone H3K9 methylation in PBMCs of GD patients was significantly decreased compared with that in the healthy controls (P=0.007). The expressions of HMTs (SUV39H1 and SUV39H2) at the mRNA level were significantly decreased in PBMCs from GD patients compared with healthy controls (PConclusions. These findings firstly suggested that the histone methylation was aberrant in PBMCs of GD patients, which could be possibly attributed to the deregulation of epigenetic modifier genes. Abnormal histone methylation modification may be involved in the pathogenesis of GD.
- 24 June 2019
- Published by Wiley in International Journal of Endocrinology
- Vol. 2019, 1-7
Open AccessAberrant Histone Methylation in Patients with Graves’ Disease
Background. Graves’ disease (GD) is an organ-specific autoimmune disease. Accumulated data have indicated that aberrant epigenetic modifications are associated with many autoimmune disorders. However, it remains unknown whether histone methylation plays a role in the pathogenesis of GD. In the present study, we aimed to assess histone modification patterns in peripheral blood mononuclear cells (PBMCs) from GD patients. The rate (degree) of H3K4 and H3K9 methylation and the expressions of histone-modifying genes were investigated.Methods. A total of 68 GD patients and 32 healthy controls were enrolled in this study. Global histone H3K4/H3K9 methylation of PBMCs was evaluated by the EpiQuik™ global histone H3K4/H3K9 methylation assay kit. The expressions of histone methyltransferases (HMTs) and histone demethylases (HDMs) at the mRNA level were determined by real-time quantitative polymerase chain reaction.Results. Global histone H3K9 methylation in PBMCs of GD patients was significantly decreased compared with that in the healthy controls (P=0.007). The expressions of HMTs (SUV39H1 and SUV39H2) at the mRNA level were significantly decreased in PBMCs from GD patients compared with healthy controls (PConclusions. These findings firstly suggested that the histone methylation was aberrant in PBMCs of GD patients, which could be possibly attributed to the deregulation of epigenetic modifier genes. Abnormal histone methylation modification may be involved in the pathogenesis of GD.
- Open Access
- 15 January 2019
- Published by Wiley in International Journal of Endocrinology
- Vol. 2019, 1-7
IRF7 Gene Variations Confer Susceptibility to Autoimmune Thyroid Diseases and Graves’ Ophthalmopathy
The objective of this study was to investigate whether IRF7 polymorphisms are associated with autoimmune thyroid diseases (AITDs). We selected three single nucleotide polymorphisms (SNPs) of IRF7, namely, rs1061501, rs1131665, and rs1061502 for genotyping using PCR-based ligase detection reaction (LDR) method in a total of 1659 participants (592 with Graves’ disease, 297 with Hashimoto’s thyroiditis, and 770 healthy controls). Gene-disease and genotype-clinical phenotype associations were evaluated for the three SNPs. Our results showed that the AG genotype and the minor allele G frequency of rs1131665 and rs1061502 in AITD patients were both higher than those of the controls (rs1131665: AG genotype: , ; allele G: , ; rs1061502: AG genotype: , ; allele G: , ). Subgroup analysis also showed that the AG genotype and the minor allele G frequency of rs1131665 and rs1061502 in Graves’ disease patients were both higher than those of the controls (rs1131665: AG genotype: , ; allele G: , ; rs1061502: AG genotype: , ; allele G: , ). Furthermore, the allele G frequency of rs1061501 was associated with Graves’ ophthalmopathy (, ). No significant difference in IRF7 polymorphisms was found between Hashimoto’s thyroiditis patients and controls. Our study has revealed for the first time that IRF7 is a susceptibility gene for AITD, especially for Graves’ disease and Graves’ ophthalmopathy.- 15 January 2019
- Published by Wiley in International Journal of Endocrinology
- Vol. 2019, 1-7
Open AccessIRF7 Gene Variations Confer Susceptibility to Autoimmune Thyroid Diseases and Graves’ Ophthalmopathy
The objective of this study was to investigate whether IRF7 polymorphisms are associated with autoimmune thyroid diseases (AITDs). We selected three single nucleotide polymorphisms (SNPs) of IRF7, namely, rs1061501, rs1131665, and rs1061502 for genotyping using PCR-based ligase detection reaction (LDR) method in a total of 1659 participants (592 with Graves’ disease, 297 with Hashimoto’s thyroiditis, and 770 healthy controls). Gene-disease and genotype-clinical phenotype associations were evaluated for the three SNPs. Our results showed that the AG genotype and the minor allele G frequency of rs1131665 and rs1061502 in AITD patients were both higher than those of the controls (rs1131665: AG genotype: , ; allele G: , ; rs1061502: AG genotype: , ; allele G: , ). Subgroup analysis also showed that the AG genotype and the minor allele G frequency of rs1131665 and rs1061502 in Graves’ disease patients were both higher than those of the controls (rs1131665: AG genotype: , ; allele G: , ; rs1061502: AG genotype: , ; allele G: , ). Furthermore, the allele G frequency of rs1061501 was associated with Graves’ ophthalmopathy (, ). No significant difference in IRF7 polymorphisms was found between Hashimoto’s thyroiditis patients and controls. Our study has revealed for the first time that IRF7 is a susceptibility gene for AITD, especially for Graves’ disease and Graves’ ophthalmopathy. - Open Access
- 11 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-7
Polymorphisms in Autophagy-Related Gene IRGM Are Associated with Susceptibility to Autoimmune Thyroid Diseases
Background. To date, studies have shown that polymorphisms in an autophagy-related gene, IRGM, are linked with different diseases, especially autoimmune diseases. The present study aimed to examine the roles of IRGM polymorphisms in autoimmune thyroid diseases (AITD). Methods. Three polymorphisms in IRGM gene (rs10065172, rs4958847, and rs13361189) were genotyped in 1569 participants (488 with Graves’ disease, 292 with Hashimoto’s thyroiditis, and 789 healthy controls) using PCR-based ligase detection reaction method. Gene-disease associations were evaluated for the three SNPs. Results. T allele of rs10065172, A allele of rs4958847, and C allele of rs13361189 were all higher in Graves’ disease patients than controls, and the ORs were OR = 1.207 (), OR = 1.207 (), and OR = 1.200 (), respectively. After adjusting for sex and age, rs10065172 and rs13361189 were still associated with GD under both the allele model and dominant model, and the adjusted ORs for rs10065172 were 1.20 () and 1.33 (), while the adjusted ORs for rs13361189 were 1.19 () and 1.33 (), respectively. No significant difference was found between Hashimoto’s thyroiditis patients and controls. Haplotype analysis found that CTA frequency was distinguishingly higher in Graves’ disease patients (OR = 1.195, ). The frequency of TCG haplotype was distinguishingly lower in AITD and Graves’ disease patients (OR = 0.861, ; OR = 0.816, ). Conclusions. Our study reveals IRGM as a susceptibility gene of AITD and Graves’ disease for the first time.- 11 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-7
Open AccessPolymorphisms in Autophagy-Related Gene IRGM Are Associated with Susceptibility to Autoimmune Thyroid Diseases
Background. To date, studies have shown that polymorphisms in an autophagy-related gene, IRGM, are linked with different diseases, especially autoimmune diseases. The present study aimed to examine the roles of IRGM polymorphisms in autoimmune thyroid diseases (AITD). Methods. Three polymorphisms in IRGM gene (rs10065172, rs4958847, and rs13361189) were genotyped in 1569 participants (488 with Graves’ disease, 292 with Hashimoto’s thyroiditis, and 789 healthy controls) using PCR-based ligase detection reaction method. Gene-disease associations were evaluated for the three SNPs. Results. T allele of rs10065172, A allele of rs4958847, and C allele of rs13361189 were all higher in Graves’ disease patients than controls, and the ORs were OR = 1.207 (), OR = 1.207 (), and OR = 1.200 (), respectively. After adjusting for sex and age, rs10065172 and rs13361189 were still associated with GD under both the allele model and dominant model, and the adjusted ORs for rs10065172 were 1.20 () and 1.33 (), while the adjusted ORs for rs13361189 were 1.19 () and 1.33 (), respectively. No significant difference was found between Hashimoto’s thyroiditis patients and controls. Haplotype analysis found that CTA frequency was distinguishingly higher in Graves’ disease patients (OR = 1.195, ). The frequency of TCG haplotype was distinguishingly lower in AITD and Graves’ disease patients (OR = 0.861, ; OR = 0.816, ). Conclusions. Our study reveals IRGM as a susceptibility gene of AITD and Graves’ disease for the first time. - Open Access
- 1 January 2018
- Published by Bioscientifica in Endocrine Connections
- Vol. 7 (1) , 220-231
Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis
Background: Type 2 diabetes is a risk factor for testosterone deficiency and impaired sex steroid status. Some studies also investigated the association of testosterone level with diabetes risk in men, but reported controversial findings. To clarify this issue, we conducted a systematic review and meta-analysis. Methods: PubMed, EMBASE and Web of Science were searched for eligible cohort or nested case–control studies published up to August 15, 2017. Meta-analysis was used to calculate the pooled relative risk (RR) of type 2 diabetes associated with higher testosterone level. Results: Thirteen cohort or nested case–control studies with 16,709 participants were included. Meta-analysis showed that higher total testosterone level could significantly decrease the risk of type 2 diabetes in men (RR = 0.65; 95% CI 0.50–0.84; P = 0.001), and higher free testosterone level could also decrease the risk of type 2 diabetes in men (RR = 0.94; 95% CI 0.90–0.99; P = 0.014). After excluding two studies that did not calculate RRs by quartiles of testosterone levels, both higher total testosterone and free testosterone levels could decrease the risk of type 2 diabetes in men, and the pooled RRs were 0.62 (95% CI 0.51–0.76; P < 0.001) and 0.77 (95% CI 0.61–0.98; P = 0.03), respectively. Conclusion: This meta-analysis suggests that higher testosterone level can significantly decrease the risk of type 2 diabetes in men. Therefore, combined with previous researches, the findings above suggest a reverse-causality scenario in the relation between testosterone deficiency and risk of type 2 diabetes in men.
- 1 January 2018
- Published by Bioscientifica in Endocrine Connections
- Vol. 7 (1) , 220-231
Open AccessTestosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis
Background: Type 2 diabetes is a risk factor for testosterone deficiency and impaired sex steroid status. Some studies also investigated the association of testosterone level with diabetes risk in men, but reported controversial findings. To clarify this issue, we conducted a systematic review and meta-analysis. Methods: PubMed, EMBASE and Web of Science were searched for eligible cohort or nested case–control studies published up to August 15, 2017. Meta-analysis was used to calculate the pooled relative risk (RR) of type 2 diabetes associated with higher testosterone level. Results: Thirteen cohort or nested case–control studies with 16,709 participants were included. Meta-analysis showed that higher total testosterone level could significantly decrease the risk of type 2 diabetes in men (RR = 0.65; 95% CI 0.50–0.84; P = 0.001), and higher free testosterone level could also decrease the risk of type 2 diabetes in men (RR = 0.94; 95% CI 0.90–0.99; P = 0.014). After excluding two studies that did not calculate RRs by quartiles of testosterone levels, both higher total testosterone and free testosterone levels could decrease the risk of type 2 diabetes in men, and the pooled RRs were 0.62 (95% CI 0.51–0.76; P < 0.001) and 0.77 (95% CI 0.61–0.98; P = 0.03), respectively. Conclusion: This meta-analysis suggests that higher testosterone level can significantly decrease the risk of type 2 diabetes in men. Therefore, combined with previous researches, the findings above suggest a reverse-causality scenario in the relation between testosterone deficiency and risk of type 2 diabetes in men.
- Open Access
- 3 August 2017
- Published by Wiley in International Journal of Endocrinology
- Vol. 2017, 1-9
Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
As there are no previous studies on the interleukin-22 (IL-22) variants in autoimmune thyroid disease (AITD), the present study aimed to explore the association between polymorphisms of IL-22 and the predisposition to AITD. The study had 975 AITD patients, including 639 Graves’ disease (GD) and 336 Hashimoto’s thyroiditis (HT) individuals and 851 healthy cohorts. Ligase detection reaction (LDR) and direct sequencing method were used for genotyping the IL-22 gene polymorphisms at rs2046068, rs2227478, rs2227485, rs11611206, and rs1179251. In comparison to female controls, genotype CC of rs1179251 was increased in the female AITD patients. Alleles C at rs2046068, C at rs2227478, and C at rs1179251 linked to the susceptibility of HT males. Genotype CC in rs1179251 was higher in male HT. Variants at rs2046068, rs2227478, and rs1179251 were associated with the AITD teenagers. Besides, genotype GG in rs11611206 was correlated with thyroid-associated ophthalmopathy (TAO). Moreover, allele G at rs11611206 was associated with decreased risk for TAO by 28.9%. Similarly, genotype CC of rs1179251 and genotype GG of rs11611206 were associated with Graves’ ophthalmopathy (GO). Allele G in rs11611206 increased people with HT towards the predisposition of hypothyroidism. In conclusion, genetic variants of IL-22 are associated with the occurrence of AITD.
- 3 August 2017
- Published by Wiley in International Journal of Endocrinology
- Vol. 2017, 1-9
Open AccessVariants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
As there are no previous studies on the interleukin-22 (IL-22) variants in autoimmune thyroid disease (AITD), the present study aimed to explore the association between polymorphisms of IL-22 and the predisposition to AITD. The study had 975 AITD patients, including 639 Graves’ disease (GD) and 336 Hashimoto’s thyroiditis (HT) individuals and 851 healthy cohorts. Ligase detection reaction (LDR) and direct sequencing method were used for genotyping the IL-22 gene polymorphisms at rs2046068, rs2227478, rs2227485, rs11611206, and rs1179251. In comparison to female controls, genotype CC of rs1179251 was increased in the female AITD patients. Alleles C at rs2046068, C at rs2227478, and C at rs1179251 linked to the susceptibility of HT males. Genotype CC in rs1179251 was higher in male HT. Variants at rs2046068, rs2227478, and rs1179251 were associated with the AITD teenagers. Besides, genotype GG in rs11611206 was correlated with thyroid-associated ophthalmopathy (TAO). Moreover, allele G at rs11611206 was associated with decreased risk for TAO by 28.9%. Similarly, genotype CC of rs1179251 and genotype GG of rs11611206 were associated with Graves’ ophthalmopathy (GO). Allele G in rs11611206 increased people with HT towards the predisposition of hypothyroidism. In conclusion, genetic variants of IL-22 are associated with the occurrence of AITD.
- Open Access
- 20 August 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (8) , 1369
TNFSF4 Gene Variations Are Related to Early-Onset Autoimmune Thyroid Diseases and Hypothyroidism of Hashimoto’s Thyroiditis
The aim of the current study was to examine whether the polymorphism loci of the tumor necrosis factor superfamily member 4 (TNFSF4) gene increase the risk of susceptibility to autoimmune thyroid diseases (AITDs) in the Han Chinese population, and a case-control study was performed in a set of 1,048 AITDs patients and 909 normal healthy controls in the study. A total of four tagging single nucleotide polymorphisms (SNPs) in the TNFSF4 region, including rs7514229, rs1234313, rs16845607 and rs3850641, were genotyped using the method of ligase detection reaction. An association between GG genotype of rs3850641 in TNFSF4 gene and AITDs was found (p = 0.046). Additionally, the clinical sub-phenotype analysis revealed a significant association between GG genotype in rs7514229 and AITDs patients who were ≤18 years of age. Furthermore, rs3850641 variant allele G was in strong association with hypothyroidism in Hashimoto’s thyroiditis (HT) (p = 0.018). The polymorphisms of the TNFSF4 gene may contribute to the susceptibility to AITDs pathogenesis.
- 20 August 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (8) , 1369
Open AccessTNFSF4 Gene Variations Are Related to Early-Onset Autoimmune Thyroid Diseases and Hypothyroidism of Hashimoto’s Thyroiditis
The aim of the current study was to examine whether the polymorphism loci of the tumor necrosis factor superfamily member 4 (TNFSF4) gene increase the risk of susceptibility to autoimmune thyroid diseases (AITDs) in the Han Chinese population, and a case-control study was performed in a set of 1,048 AITDs patients and 909 normal healthy controls in the study. A total of four tagging single nucleotide polymorphisms (SNPs) in the TNFSF4 region, including rs7514229, rs1234313, rs16845607 and rs3850641, were genotyped using the method of ligase detection reaction. An association between GG genotype of rs3850641 in TNFSF4 gene and AITDs was found (p = 0.046). Additionally, the clinical sub-phenotype analysis revealed a significant association between GG genotype in rs7514229 and AITDs patients who were ≤18 years of age. Furthermore, rs3850641 variant allele G was in strong association with hypothyroidism in Hashimoto’s thyroiditis (HT) (p = 0.018). The polymorphisms of the TNFSF4 gene may contribute to the susceptibility to AITDs pathogenesis.